HomeRPRX • NASDAQ
Royalty Pharma plc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 609.29M | 7.90% |
Operating expense | 169.00M | 195.35% |
Net income | 288.22M | -47.02% |
Net profit margin | 47.30 | -50.90% |
Earnings per share | 1.17 | 12.81% |
EBITDA | 429.43M | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 955.04M | -4.36% |
Total assets | 19.35B | 7.23% |
Total liabilities | 9.73B | 24.96% |
Total equity | 9.62B | — |
Shares outstanding | 427.25M | — |
Price to book | 2.64 | — |
Return on assets | 5.68% | — |
Return on capital | 5.93% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 288.22M | -47.02% |
Cash from operations | 702.62M | -0.14% |
Cash from investing | -958.31M | 19.65% |
Cash from financing | 562.74M | 272.88% |
Net change in cash | 307.04M | 137.69% |
Free cash flow | -738.93M | 17.46% |
Previous close
$39.46
Day range
$37.83 - $39.69
Year range
$24.05 - $41.24
Market cap
21.84B USD
Avg Volume
3.32M
P/E ratio
21.65
Dividend yield
2.32%
Primary exchange
NASDAQ
About
Founded
1996
Website
Employees
99
